Acute cervical dystonia following the BNT162b2 mRNA COVID-19 vaccine

被引:6
|
作者
Algahtani, Hussein A. [1 ,2 ,3 ,5 ]
Shirah, Bader H. [4 ]
Alwafi, Emad [1 ,2 ,3 ]
机构
[1] King Abdul Aziz Med City, Dept Med, Jeddah, Saudi Arabia
[2] King Abdullah Int Med Res Ctr, Jeddah, Saudi Arabia
[3] King Saud bin Abdulaziz Univ Hlth Sci, Coll Med, Jeddah, Saudi Arabia
[4] King Faisal Specialist Hosp & Res Ctr, Dept Neurosci, Jeddah, Saudi Arabia
[5] King Abdul Aziz Med City, Dept Med, POB 12723, Jeddah 21483, Saudi Arabia
关键词
Cervical Dystonia; COVID-19; Vaccine; BNT162b2; mRNA; Saudi Arabia;
D O I
10.1016/j.clineuro.2022.107304
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The coronavirus disease of 2019 (COVID-19) pandemic is caused by a novel coronavirus SARS-Cov-2. Four major vaccine types are being used to fight against this deadly pandemic and save precious human lives. All types of vaccines have been associated with a risk of neurological complications ranging from mild to severe. Cervical dystonia occurring after a COVID-19 vaccine was not previously reported in the literature. In this article, we describe a case of acute cervical dystonia occurring after the first dose of the BNT162b2 COVID-19 vaccine. We attribute the occurrence of cervical dystonia to the vaccine due to the temporal relationship. This report adds to the literature a possible rare side effect of a COVID-19 vaccine and contributes to the limited literature on potential neurological side effects of mRNA-based vaccines. The likely mechanism is autoimmune. Further research is needed to probe and study the exact mechanism.
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Acute hepatitis following mRNA BNT162b2 COVID-19 vaccination
    Cheah, Matthew
    Girgis, Safwat
    Bain, Vincent G.
    CANADIAN LIVER JOURNAL, 2022, 5 (04): : 535 - 539
  • [2] BNT162b2 COVID-19 vaccine
    不详
    AUSTRALIAN PRESCRIBER, 2021, 44 (02) : 57 - 58
  • [3] Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy
    Dagan, Noa
    Barda, Noam
    Biron-Shental, Tal
    Makov-Assif, Maya
    Key, Calanit
    Kohane, Isaac S.
    Hernan, Miguel A.
    Lipsitch, Marc
    Hernandez-Diaz, Sonia
    Reis, Ben Y.
    Balicer, Ran D.
    NATURE MEDICINE, 2021, 27 (10) : 1693 - +
  • [4] Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy
    Noa Dagan
    Noam Barda
    Tal Biron-Shental
    Maya Makov-Assif
    Calanit Key
    Isaac S. Kohane
    Miguel A. Hernán
    Marc Lipsitch
    Sonia Hernandez-Diaz
    Ben Y. Reis
    Ran D. Balicer
    Nature Medicine, 2021, 27 : 1693 - 1695
  • [5] BNT162b2 mRNA COVID-19 Vaccine: First Approval
    Lamb, Yvette N.
    DRUGS, 2021, 81 (04) : 495 - 501
  • [6] Cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine
    Lopez-Valle, Alba
    Falkenhain-Lopez, Daniel
    Arranz, Celia R.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2021, 60 (07) : 891 - 892
  • [7] Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
    Polack, Fernando P.
    Thomas, Stephen J.
    Kitchin, Nicholas
    Absalon, Judith
    Gurtman, Alejandra
    Lockhart, Stephen
    Perez, John L.
    Perez Marc, Gonzalo
    Moreira, Edson D.
    Zerbini, Cristiano
    Bailey, Ruth
    Swanson, Kena A.
    Roychoudhury, Satrajit
    Koury, Kenneth
    Li, Ping
    Kalina, Warren V.
    Cooper, David
    Frenck, Robert W., Jr.
    Hammitt, Laura L.
    Tureci, Ozlem
    Nell, Haylene
    Schaefer, Axel
    Unal, Serhat
    Tresnan, Dina B.
    Mather, Susan
    Dormitzer, Philip R.
    Sahin, Ugur
    Jansen, Kathrin U.
    Gruber, William C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (27): : 2603 - 2615
  • [8] Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
    Wang, Xiang
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (16): : 1577 - 1578
  • [9] Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine
    Tumminia, Andrea
    Romano, Marcello
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (02): : 191 - 191
  • [10] BNT162b2 mRNA COVID-19 Vaccine: First Approval
    Yvette N. Lamb
    Drugs, 2021, 81 : 495 - 501